Outlook on Sector Performance: More Pain Ahead for Financials [View article]
Lazy people look at the market index to buy big, well-known stocks; thinking they are safer and better investment...if it's that eazy, we'll be all multi-millionaires.
Do a dd like you own the company before investing, that's the only way.
Weekly Outlook: Reading the Market Tea Leaves [View article]
Lazy people look at the market index to buy big, well-known stocks; thinking they are safer and better investment...if it's that eazy, we'll be all multi-millionaires.
Bullish Signal from the Global Volatility Index [View article]
Lazy people look at the market index to buy big, well-know stocks; thinking they are safer and better investment...if it's that eazy, we'll be all multi-millionaires.
Investing in Stem Cell Stocks: Growth Industry of the Future? [View article]
Thermogenesis (KOOL) is shooting to become the 1st profitable stem cell company from operation next quarter(April-June, 2009).
Most stem cell companies have no product, no revenue, on constant life-support (burning money from fund infused by investors); in other words, running on fumes with lots of pipe dreams.
Outlook Is Bleak for Bank of America [View article]
My pick for 2009 and beyond...? Thermogenesis (KOOL).
Should be the 1st profitable stem cell company from operation. No debt, plenty of cash and tons of pricing power (just raised price 25% of its products) because no real competition to its products.
Do your dd like you own the company before investing as always.
Cramer's Lightning Round - Off Target (1/23/09) [View article]
I took a good look at some of the "hot" stem cell companies last couple of days and here is my take.....
The hottest are GERN and STEM and these two are really a pair of jokes.....
1. They both have no real revenue and a ton of loss every year and for the foreseeable future.
2. They actually are some R&D shops with lots of patents and all their clinical trials are at very prelimary stage at least 5 years away from any commercial value if there is any.
3. Their current market value are insanely high and they all have at least a few pumping analysts and institutional writers to pump them.
4. These two are like the legal crap shooting machine, best play for day-traders.
Amazing.... no real products, no real revenue (tiny revenue from cash interest income) and a HUGE pipe dream that are being trading for hundreds of millions value.
THEREFORE:
My pick for 2009 and beyond is Thermogenesis (KOOL).
KOOL should be the 1st profitable stem cell company from operation with real product lines and revenue. No debt, plenty of cash, tons of pricing power (just raised price 25% of its products), no competition and huge market to grow for the next 10 years.
Sort by:
Latest | Highest ratedOutlook on Sector Performance: More Pain Ahead for Financials [View article]
Do a dd like you own the company before investing, that's the only way.
I'be been bullish since November 21, 2008...
finance.yahoo.com/echa...;range=1m;indicator=vo...
Weekly Outlook: Reading the Market Tea Leaves [View article]
finance.yahoo.com/echa...;range=1m;indicator=vo...
Do a dd like you own the company before investing, that's the only way.
I'be been bullish since November 21, 2008...
Bullish Signal from the Global Volatility Index [View article]
finance.yahoo.com/echa...;range=1m;indicator=vo...
I'be been bullish since November 21, 2008...
After January's Chill, Where Will the Market Thaw First? [View article]
finance.yahoo.com/echa...;range=1m;indicator=vo...
After January's Chill, Where Will the Market Thaw First? [View article]
check this out...
finance.yahoo.com/echa...
The (Skeptical) Macro Economic Case for Optimism [View article]
finance.yahoo.com/echa...;range=1m;indicator=vo...
Obama's Role in the Market's Next Breakout [View article]
check this out...
finance.yahoo.com/echa...;range=1m;indicator=vo...
Bullish Sentiment: The Decline Continues [View article]
check this out...
finance.yahoo.com/echa...;range=1m;indicator=vo...
Worst January in S&P History Bodes Poorly for Rest of 2009 [View article]
The New Economic Reality [View article]
Growth Stocks Clobbering Value [View article]
More Green Days for the Dow, Thanks to the Fed [View article]
Some are up almost 100% already like KOOL and another like SNDK isn't too bad either.
KOOL will be at least a 10 bagger from today's price in 2 years while SNDK could be a 5 bagger in 3-5 years.
Investing in Stem Cell Stocks: Growth Industry of the Future? [View article]
Most stem cell companies have no product, no revenue, on constant life-support (burning money from fund infused by investors); in other words, running on fumes with lots of pipe dreams.
Outlook Is Bleak for Bank of America [View article]
Should be the 1st profitable stem cell company from operation. No debt, plenty of cash and tons of pricing power (just raised price 25% of its products) because no real competition to its products.
Do your dd like you own the company before investing as always.
Cramer's Lightning Round - Off Target (1/23/09) [View article]
The hottest are GERN and STEM and these two are really a pair of jokes.....
1. They both have no real revenue and a ton of loss every year and for the foreseeable future.
2. They actually are some R&D shops with lots of patents and all their clinical trials are at very prelimary stage at least 5 years away from any commercial value if there is any.
3. Their current market value are insanely high and they all have at least a few pumping analysts and institutional writers to pump them.
4. These two are like the legal crap shooting machine, best play for day-traders.
Amazing.... no real products, no real revenue (tiny revenue from cash interest income) and a HUGE pipe dream that are being trading for hundreds of millions value.
THEREFORE:
My pick for 2009 and beyond is Thermogenesis (KOOL).
KOOL should be the 1st profitable stem cell company from operation with real product lines and revenue. No debt, plenty of cash, tons of pricing power (just raised price 25% of its products), no competition and huge market to grow for the next 10 years.